ARCHIVES

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

This article is from The Cancer Letter archive.

Vol. 25 No. 10 | March 12, 1999

Download PDF Visit The Full Archive

Related Articles

Guidelines Adopted For Pathology Review

February 22, 1980

Sequestration: $1.71 Billion Cut to NIH Budget Will Reduce Number of RPGs

May 17, 2013

Funding Opportunities: ONS Biotherapy Phase II, Outcomes-Research Grant

August 3, 2001

White House Preparing To Nominate Andrew von Eschenbach as FDA Commissioner, Sources Said

March 3, 2006

Interferon “Hysteria” Prompts ASCO To Warn Against Expecting Immediate Benefits

June 20, 1980

Cell Culture ID Offered By NIC

January 7, 1983